109 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Buyback programs - November 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - december 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - october 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
Public releases | ||
Buyback programs - September 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
Press releases communication | ||
Rapport financier semestriel 2023 (french) Rapport financier semestriel 2023 (french) |
Half Year Report | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - August 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
Public releases | ||
2023 Half-Year Results Contents |
Half Year Report | ||
Buyback programs - July Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights - July 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
Press releases communication | ||
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
Agenda | ||
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
Half Year Report | ||
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
Press releases communication | ||
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
Shareholders´s Meeting | ||
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
Shareholders´s Meeting | ||
3rd generation appointed chairman of the board of directors of VETOQUINOL SA At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023. |
Press releases communication | ||
Assemblée générale - Vetoquinol SA 25 mai 2023 Ordre du jour : |
Shareholders´s Meeting | ||
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – record date Conformément aux dispositions des articles L233-8-II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers |
Shareholders´s Meeting | ||
Universal registration document 2022 Universal Registration Document including the Annual Financial Report |
Reference document | ||
Essential products Essential products for the most common needs |
Press releases communication | ||
Worlds Top 10 The animal health company is firmly established in the world's Top 10. |
Press releases communication | ||
Q1 2023 Sales: €145M Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates. |
Public releases | ||
BALO : Avis de convocation / avis de réunion Mesdames et Messieurs les actionnaires sont convoqués le jeudi 25 mai 2023 à 11h00 au siège social, Magny-Vernois 70200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions ci-après. |
Shareholders´s Meeting | ||
Document d’enregistrement universel (URD) 2022 version XBRL Document d'enregistrement universel 2022 incluant le rapport financier annuel |
Reference document | ||
Availability of the 2022 universal registration document On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
Monthly information regarding the total number of voting rights - April 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - May 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - June 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - March 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Clone of Buyback programs – April 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – May 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – June 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – March 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
A visionary strategy The key steps of a visionary strategy |
Press releases communication | ||
[VIDEO] Présentation des résultats annuels 2022 -French Présentation analystes & investisseurs - 23 Mars 2023 |
Annual Report | ||
ANNUAL RESULTS 2022 (slideshow) 01.2022 Highlights |
Annual Report | ||
2022 ANNUAL RESULTS Annual sales: €540m (up 3.6% as reported) |
Public releases | ||
Serving animal Health - 90 years Serving animal Health for over 90 years |
Press releases communication | ||
Monthly information regarding the total number of voting rights - February 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the « Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - February 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights - January 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - January 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
Press releases communication | ||
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
Public releases | ||
CALENDAR 2023 Stock exchange market – non authorized periods The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities. |
Financial Documents | ||
2023 calendar of financial communication Vetoquinol published its calendar of financial communication for 2023. |
Agenda | ||
Monthly information regarding the total number of voting rights - december 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - december 2022 Monthly communication regarding buyback programs |
Description of buyback programs | ||
2021 calendar of financial communication December 15, 2020 (Lure, France) - Vetoquinol published its calendar of financial communication for 2021. |
Agenda | ||
Programme de rachat - November 2020 |
Monthly communication regarding buyback programs | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - October2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - October 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Q3 2020 sales: €114.5 million* (Up 14.3%) Vetoquinol posted sales of €114.5 million for the third quarter of 2020, up 14.3% as reported compared to the same period last year. |
Public releases | ||
Programme de rachat - September 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Monthly information regarding the total number of voting rights and shares making of the share capital -September 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »
|
Voting rights | ||
VETOQUINOL, SNGTV and FARMVETSYSTEMS sign a partnership agreement to offer a common, innovative digital solution to the veterinary healthcare market. September 28th, 2020 (Paris, France) VETOQUINOL, FARMVET SYSTEMS and SNGTV have signed a partnership agreement aimed at offering a common solution highlighting the complementarity of their two software, VetIMPRESS and Vetélevage to farm vets. Aware of their shared philosophy aimed at optimizing vets actions thanks to new digital technologies, they are pooling these two software programs to strengthen the role of farm vets in animal health and welfare. |
Public releases | ||
Vetimpress delivering digital solutions to farm vets with a growing network of partnerships September 21st, 2020 (Northern Ireland) – VetIMPRESS the secure data management platform has recently implemented a series of integrations, reinforcing its position as a leading source of information for farm animal vets. The platform has grown its connections to over 100 external sources across 10 countries. The partnerships are set to improve connectivity across the industry, providing a single source of truth to better inform ethical, safe and productive veterinary decisions. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital -Aout 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - August 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Vetoquinol finalizes the acquisition of Profender® and Drontal® product families September 1st, 2020 (Lure, France) – Vetoquinol confirms the completion of the acquisition of Profender® and Drontal® product families for the European Economic Area and the UK. This acquisition is effective from August 1st, 2020. |
Public releases | ||
Programme de rachat - July 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Monthly information regarding the total number of voting rights and shares making of the share capital -July 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
2020 Half year Financial Report (french) Half year Financial Report |
Half Year Report | ||
[VIDEO] Présentation des résultats semestriels 2020 - french |
Half Year Report | ||
H1 2020 results H1 2020 Result
|
Half Year Report | ||
2020 first half results consolidated sales: €196.1m (up 7.5% at constant exchange rates) net income group share: €15.1m (7.7% of sales) At its meeting on July 29, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the first half 2020 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital -June 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Bilan semestriel des moyens alloués au contrat de liquidité - french Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 30 juin 2020 |
Liquidity contract | ||
Programme de rachat - June 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Vetoquinol is moving forward with the acquisition of Profender® and Drontal® and related pipeline assets following communication from the European commission June 9th, 2020 (Lure, France) - The European Commission (EC) has approved, under the EU merger Regulation, the proposed acquisition of Bayer’s Animal Health Division by Elanco Animal Health. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital -May 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - May 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Rémunération et politique des dirigeants (french) Résultats des votes de l’Assemblée Générale Mixte du 26 mai 2020 |
Shareholders´s Meeting | ||
Descriptif du programme de rachat d’actions propres soumis à l’assemblée générale mixte du 26 mai 2020 (french) Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions autorisé par l’assemblée générale mixte du 26 mai 2020. |
Description of buyback programs | ||
Combined Ordinary and Extraordinary General Meeting of May 26, 2020 The Combined Ordinary and Extraordinary General Meeting of Vetoquinol shareholders was held on Tuesday May 26, 2020 in Lure, chaired by Etienne Frechin. The shareholders did not physically attend this meeting in view of the restrictions on gatherings due to the health crisis in France. |
Shareholders´s Meeting | ||
Résultats du scrutin de l'Assemblée Générale mixte du 26 mai 2020 (french) Résultats du scrutin |
Shareholders´s Meeting | ||
Assemblée Générale Annuelle Mixte (french) 26 mai 2020 |
Shareholders´s Meeting | ||
Brochure Vetoquinol AGM en huis clos Mesdames et Messieurs les actionnaires,
Le conseil d’administration a décidé de faire usage des dispositions de l’ordonnance n°2020-321 du 25 mars 2020 portant adaptation des règles de réunion et de délibération des assemblées et organes dirigeants des personnes morales et entités dépourvues de personnalité morale de droit privé en raison de la crise sanitaire actuelle et des restrictions de déplacement et réunion qu’elle impose. En conséquence, l’assemblée générale mixte de VETOQUINOL SA se tiendra le mardi 26 mai 2020 à 14h45, au siège social, Magny-Vernois 70 200 LURE, à huis clos, sans que les actionnaires et les autres personnes ayant le droit d’y assister ne soient présents physiquement.
|
Shareholders´s Meeting | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2020 |
Voting rights | ||
Programme de rachat - April 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Dominique Derveaux appointed Group Chief Operations Officer
Effective April 1, 2020, Vetoquinol’s Board of Directors has appointed Dominique Derveaux Group Chief Operations Officer. In this capacity, he will run the Business, Marketing & Medical, Industrial, and Information Systems departments. He will report to Vetoquinol CEO Matthieu Frechin. |
Public releases | ||
Availability of the 2019 universal registration document Vetoquinol informs that it has filed its 2019 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 23, 2020. |
Public releases | ||
2019 Universal registration document Note to recipient of this document: this is the translation of an extract of the Universal Registration Document and Annual Financial Report for the year ended December 31, 2019. The original French document was filed with the AMF (French Financial Markets Authority) on April 23, 2020.
|
Reference document | ||
Q1 2020 sales €103.4 million (Up 13.7%) Vetoquinol Group sales for Q1 2020 amounted to €103.4 million, up 13.7% as reported and up 13.4% at constant exchange rates. |
Public releases | ||
Formulaire de vote Formulaire de vote - Assemblée générale mixte - 26 mai 2020 - siège social Magny-Vernois 70200 LURE |
Shareholders´s Meeting | ||
Avis de réunion valant avis de convocation (french) Mesdames et Messieurs les actionnaires sont convoqués le mardi 26 mai 2020 à 14h45, au siège social, Magny-Vernois 70 200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions suivants : |
Shareholders´s Meeting | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - MArch 2020 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - March 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
Monthly communication regarding buyback programs | ||
[AUDIO] Présentation des résultats 2019 Présentation analystes & investisseurs - 26 mars 2020 |
Annual Report | ||
2019 annual results
|
Annual Report | ||
2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales) At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
Public releases | ||
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (23 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
Monthly communication regarding buyback programs | ||
Covid-19: Vetoquinol donates masks to neighboring healthcare facilities Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions. |
Public releases |